{"disease":{"id":"prevention-of-migraine-attacks","name":"Prevention of migraine attacks","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"nurtec-odt","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nurtec Odt","generic_name":"Rimegepant Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist","quality_score":85,"revenue":"1424","mechanism":"Rimegepant is a calcitonin gene-related peptide receptor antagonist."},{"drug_id":"rimegepant-75mg-every-other-day-dosing","indication_name":"Prevention of migraine attacks in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75mg every other day dosing","generic_name":"rimegepant-75mg-every-other-day-dosing","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"calcitonin gene-related peptide receptor","drug_class":"calcitonin gene-related peptide receptor antagonist","quality_score":64,"revenue":"798","mechanism":"Rimegepant targets the calcitonin gene-related peptide receptor to treat migraines."},{"drug_id":"fremanezumab","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajovy","generic_name":"FREMANEZUMAB","company_name":"Teva","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide 1","drug_class":"","quality_score":66,"revenue":"600","mechanism":"Ajovy works by blocking the action of calcitonin gene-related peptide 1 (CGRP1), a molecule involved in pain transmission."},{"drug_id":"erenumab","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aimovig","generic_name":"ERENUMAB","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Calcitonin-gene-related peptide receptor","drug_class":"","quality_score":70,"revenue":"500","mechanism":"Aimovig works by blocking the calcitonin-gene-related peptide receptor, a protein involved in migraine pain."},{"drug_id":"eptinezumab","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vyepti","generic_name":"EPTINEZUMAB","company_name":"Lundbeck Seattle BioPharmaceuticals, Inc.","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide 1","drug_class":"Calcitonin Gene-related Peptide Antagonist [EPC]","quality_score":66,"revenue":"300","mechanism":"Vyepti works by blocking the action of calcitonin gene-related peptide 1, a molecule involved in migraine pain."},{"drug_id":"rimegepant-75mg-daily-dosing","indication_name":"Prevention of migraine attacks in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75mg daily dosing","generic_name":"rimegepant-75mg-daily-dosing","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"calcitonin gene-related peptide receptor","drug_class":"calcitonin gene-related peptide receptor antagonist","quality_score":53,"revenue":null,"mechanism":"Rimegepant is a calcitonin gene-related peptide receptor antagonist that inhibits the release of pro-inflammatory peptides."},{"drug_id":"eptinezumab-jjmr","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"VYEPTI","generic_name":"EPTINEZUMAB-JJMR","company_name":"Lundbeck Seattle BioPharmaceuticals, Inc.","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide 1, Calcitonin gene-related peptide 2","drug_class":"Calcitonin Gene-related Peptide Antagonist [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"rimegepant","indication_name":"Prevention of migraine attacks","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nurtec Odt","generic_name":"rimegepant","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"calcitonin gene-related peptide receptor","drug_class":"Calcitonin Gene-related Peptide Receptor Antagonist","quality_score":70,"revenue":null,"mechanism":"Rimegepant blocks the calcitonin gene-related peptide receptor."}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}